e-learning
resources
Paris 2018
Sunday, 16.09.2018
Pulmonary fibrosis: from models to patients
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis
P. Ogger, T. Maher (t.maher@rbht.nhs.uk / Royal Brompton Hospital,London), C. Lloyd (c.lloyd@imperial.ac.uk / Imperial College London,London), A. Byrne (a.byrne@imperial.ac.uk / Imperial College London,London)
Source:
International Congress 2018 – Pulmonary fibrosis: from models to patients
Session:
Pulmonary fibrosis: from models to patients
Session type:
Thematic Poster
Number:
985
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Ogger, T. Maher (t.maher@rbht.nhs.uk / Royal Brompton Hospital,London), C. Lloyd (c.lloyd@imperial.ac.uk / Imperial College London,London), A. Byrne (a.byrne@imperial.ac.uk / Imperial College London,London). LSC - 2018 - Distinct metabolic alterations in airway macrophages during pulmonary fibrosis. 985
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
LSC - 2018 - Collagen-producing macrophages can mediate lung fibrosis throughFra-2/AP-1 expression
Source: International Congress 2018 – New insights in the signalling pathways that underlie IPF pathophysiology
Year: 2018
Increased apoptosis of alveolar lymphocytes (AL) in idiopathic pulmonary fibrosis (IPF). Potential mechanisms and practical considerations
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: clinical view
Year: 2013
Mechanisms and markers of airway inflammation in cystic fibrosis
Source: Eur Respir J 2002; 19: 333-340
Year: 2002
LSC - 2021 - Role of mitochondrial function of lung mesenchymal stem cells in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021
M2 polarized alveolar macrophages in pulmonary fibrosis
Source: Annual Congress 2005 - Pulmonary hypertension and fibrosis: novel mechanisms
Year: 2005
LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis
Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis
Year: 2021
LSC - 2020 - Altered metabolic activity and redox balance are associated with a proliferative phenotype in COPD airway smooth muscle cells.
Source: Virtual Congress 2020 – Metabolic alterations and ageing in lung disease
Year: 2020
Alterations of the soluble proteome of airway epithelial cells in COPD
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases
Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease
Year: 2015
LSC - 2020 - Characterizing lung resident mesenchymal stem cells in idiopathic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020
Characterisation of defective phagocytosis by chronic obstructive pulmonary disease alveolar macrophages
Source: International Congress 2016 – New findings in mucosal immunology
Year: 2016
Relationship between monocyte-derived macrophage phagocytosis and airway inflammation in stable COPD
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Inflammatory cytokines in airway secretions from patients with cystic fibrosis contribute to airway epithelial cell damage
Source: Eur Respir J 2004; 24: Suppl. 48, 384s
Year: 2004
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Increased fibrinolytic mediators in IPF as potential contributors to pulmonary fibrosis and vascular remodeling
Source: International Congress 2015 – IPF: from bench to bedside
Year: 2015
Treg alterations lead to systemic and local immune deregulation in idiopathic pulmonary fibrosis and collagen vascular disease-associated interstitial pneumonia
Source: Annual Congress 2007 - Cell biology of asthma and COPD
Year: 2007
LSC Abstract – Macrophage phenotype changes within the small airway wall in smokers and chronic obstructive pulmonary disease
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Alveolar lymphocytes (AL) apoptosis in interstitial lung diseases (ILD). Increased AL apoptosis rate in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis
Year: 2009
Update on the roles of distal airways in COPD
Source: Eur Respir Rev 2011; 20: 7-22
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept